In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee:
Times and Dates: 9 a.m.-5 p.m., February 16, 2012, 9 a.m.-12 p.m., February 17, 2012.
Place: CDC, Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health and Human Services, the Director, CDC, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), and the Director, Division of Healthcare Quality Promotion regarding (1) the practice of healthcare infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.
Matters To Be Discussed: The agenda will include updates on CDC's activities for Healthcare Associated Infections (HAI), CDC's dialysis HAI activities, and CDC's long-term care HAI activities, draft guideline for prevention of infections among patients in neonatal intensive care units (NICU), draft guideline for infection control in healthcare personnel, draft guideline for the prevention of surgical site infections, update from the HICPAC surveillance working group, and updates on HAI surveillance definitions.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE., Mailstop A-07, Atlanta, Georgia 30333, Telephone: (404) 639-8692, Email: firstname.lastname@example.org.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2012-2001 Filed 1-30-12; 8:45 am]
BILLING CODE 4163-18-P